Cerebral near-infrared spectroscopy monitoring versus treatment as usual for extremely preterm infants: a protocol for the SafeBoosC randomised clinical phase III trial.

Mathias Lühr HansenAdelina PellicerChristian GluudEugene DempseyJonathan MintzerSimon Hyttel-SørensenAnne Marie HeuchanCornelia HagmannEbru ErgenekonGabriel DimitriouGerhard PichlerGunnar NaulaersGuoqiang ChengHercilia GuimarãesJakub TkaczykKaren B KreutzerMonica FumagalliOlivier ClarisPetra LemmersSiv FredlyTomasz SzczapaTopun AustinJanus Christian JakobsenGorm Greisen

Published in: Trials (2019)

ClinicalTrial.gov, NCT03770741. Registered 10 December 2018.

Keyphrases

phase iii
open label
clinical trial
preterm infants
double blind
placebo controlled
phase ii
study protocol
randomized controlled trial
low birth weight
subarachnoid hemorrhage
combination therapy
preterm birth
replacement therapy